Results 151 to 160 of about 12,531 (316)

Reply to Rosenblum et al. and Carriquiry and Ommen: Understanding probative value, triers-of-fact, and usefulness of validity study results. [PDF]

Proc Natl Acad Sci U S A
Guyll M, Madon S, Yang Y, Burd KA, Wells G.   +4 more
europepmc   +1 more source

Why Our Justice System Convicts Innocent People, and the Challenges Faced by Innocence Projects Trying to Exonerate Them [PDF]

, 2011
Steven A. Krieger
openalex   +1 more source

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

Generation and Nitric Oxide Reactivity of a Cobalt(II) Superoxide Complex via Guanidine-Based Ligand Non-Innocence. [PDF]

JACS Au
Barman DJ, Lohmiller T, Krause K, Katz S, Haumann M, Hildebrandt P, Ray K.   +6 more
europepmc   +1 more source

Ruthenium Complexes with Vinyl, Styryl, and Vinylpyrenyl Ligands: A Case of Non-innocence in Organometallic Chemistry

, 2007
Jörg Maurer, Michael Linseis, Biprajit Sarkar, Brigitte Schwederski, M. Niemeyer, Wolfgang Kaim, Stanislav Záliš, Christopher E. Anson, Manfred Zabel, Rainer F. Winter   +9 more
openalex   +2 more sources

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Flipping the Conditional: Why We Are Probably Wrong About Probabilities. [PDF]

Paediatr Anaesth
Sidebotham D, Dare T.
europepmc   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

Incorrect statistical reasoning in Guyll et al. leads to biased claims about strength of forensic evidence. [PDF]

Proc Natl Acad Sci U S A
Rosenblum M, Chin ET, Ogburn EL, Nishimura A, Westreich D, Datta A, Vanderplas S, Cuellar M, Thompson WC.   +8 more
europepmc   +1 more source

Not Much Feels Right. [PDF]

J Grad Med Educ, 2023
Novack K.
europepmc   +1 more source